Understanding Key Drivers and Growth Opportunities in the Liver Diseases Therapeutics Market: Trends and Market Size Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Liver Diseases Therapeutics Market?
The liver disease therapeutics market is poised for growth, spurred on by the increasing incidence of liver diseases. This term refers to any disorder impacting the liver, which can be managed through various therapeutic treatments. For example, data from the Office for Health Improvement and Disparities, a governmental department in the UK, showed that as of April 2024, the rate of liver disease mortality for people below 75 in England had risen to 21.4 per 100,000 of the population in 2022. Notably, males had 6,664 premature deaths, markedly higher than the 3,929 recorded for females. Hence, the escalating rate of liver disease prevalence is catalyzing the expansion of the liver disease therapeutics market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp
#What Are the Key Projections for the CAGR of the Liver Diseases Therapeutics Market From 2025 to 2034?
In recent years, there has been significant growth in the market size for therapeutics for liver diseases. The market, which will expand from $14.16 billion in 2024 to $15.23 billion in 2025, will experience a compound annual growth rate (CAGR) of 7.6%. This growth during the historical period can be linked to the high incidence of liver diseases, patterns of alcohol consumption, improvements in diagnostic techniques, obesity and metabolic syndrome, awareness and screening initiatives, as well as government efforts to control hepatitis.
Anticipated robust expansion is on the horizon for the liver diseases therapeutics market in the coming years. It is projected to reach $20.78 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.1%. Reasons for this expected growth in the said period include precision medicine strategies, progress in RNA therapeutics, a spotlight on fibrosis cures, patient advocacy and support units, the evolution of hepatitis vaccines, and regulatory endorsement for rare drugs. Major trends paving the way for future growth encompass improvements in hepatitis C treatment, the advent of innovative therapies for liver fibrosis, advancements in immunotherapies, adoption of telemedicine and remote patient surveillance, along with a focus on nutritional interventions.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7969
What Are the Most Significant Market Trends Transforming theLiver Diseases Therapeutics Market?
Forming strategic alliances is emerging as a significant trend in the liver disease therapeutics market. Major players in this market are collaborating to enhance their dominance in the sector. For instance, in January 2022, a clinical-stage biopharmaceutical firm based in the US, Aligos Therapeutics Inc., entered into a partnership with Merck & Co, a US-based organization specializing in liver disease therapeutics. The purpose of this partnership is to explore and develop oligonucleotide treatments for non-alcoholic steatohepatitis.
What Are the Top Market Players Propelling the Growth of theLiver Diseases Therapeutics Industry?
Major companies operating in the liver diseases therapeutics market are Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals, Watson Pharmaceuticals Inc., AstraZeneca PLC, Gilead Sciences Inc., Endo International PLC, Alnylam Pharmaceuticals Inc., Provectus Biopharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc., Madrigal Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Enanta Pharmaceuticals Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
Which Primary Segments of the Liver Diseases Therapeutics Market Are Driving Growth and Industry Transformations?
The liver diseases therapeutics market covered in this report is segmented –
1) By Disease Type: Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer
2) By Treatment: Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Hepatitis: Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D
2) By Non-Alcoholic Fatty Liver Disease (NAFLD): Non-Alcoholic Steatohepatitis (NASH), Simple Fatty Liver
3) By Alcohol-Induced Liver Disease: Alcoholic Hepatitis, Alcoholic Cirrhosis
4) By Liver Cancer: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=7969&type=smpGlobal Liver Diseases Therapeutics Market, Global Liver Diseases Therapeutics Market Report, Global Liver Diseases Therapeutics Market Trends, Global Liver Diseases Therapeutics Market Size
Browse Through More Reports Similar to the Gobal Liver Diseases Therapeutics Maret 2025, By The Business Research Company:
Digital Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report
Neurodegenerative Disorder Therapeutics Global Market Report 2024
Peptide Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
